Case report: Lamivudine therapy for submassive hepatic necrosis due to reactivation of hepatitis B following chemotherapy

Journal of Gastroenterology and Hepatology (Australia)

Volumn 14, Issue 8, 1999, Pages 801-803

  Maguire, Cliona M ^a   Crawford, Darrell H G ^a   Hourigan, Luke F ^a   Clouston, Andrew D ^a   Walpole, Euan T ^a   Powell, Elizabeth E ^a  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

Chemotherapy; Hepatitis B; Immunosuppression; Lamivudine; Reactivation

Indexed keywords

ANTINEOPLASTIC AGENT; DOXORUBICIN; HEPATITIS B SURFACE ANTIGEN; LAMIVUDINE; LIVER ENZYME; VIRUS DNA;

ARTICLE; BREAST CARCINOMA; CASE REPORT; DRUG EFFICACY; FEMALE; HEPATITIS B; HUMAN; LIVER BIOPSY; LIVER NECROSIS; PRIORITY JOURNAL; RECURRENT DISEASE; TOXIC HEPATITIS;

EID: 0032836992     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.1999.01961.x     Document Type: Article

References (7)

1. 1 Kumagai K, Takagi T, Nakamura S et al. Hepatitis B virus carriers in the treatment of malignant lymphoma: An epidemiological study in Japan. Ann. Oncol. 1997; 8 (Suppl. 1): 107-9.
2. 2 Lai CL, Chien RN, Leung NW et al. A one year trial of lamivudine for chronic hepatitis B. N. Engl. J. Med. 1998; 339: 61-8.
3. 3 Nakamura Y, Motokura T, Fujita A, Yamashita T, Ogata E. Severe hepatitis related to chemotherapy in hepatitis B virus carriers with haematologic malignancies. Cancer 1996; 78: 2210-15.
4. 4 Clark FL, Drummond MW, Chambers S, Chapman BA, Patton WN. Successful treatment with lamivudine for fulminant reactivated hepatitis B infection following intensive therapy for high-grade non-Hodgkin's lymphoma. Ann. Oncol. 1998; 9: 385-7.
5. 5 Picardi M, Selleri C, de Rosa G, Raiola A, Pezzullo L, Rotoli B. Lamivudine treatment for chronic replicative hepatitis B virus infection after allogeneic bone marrow transplantation. Bone Marrow Transplant. 1998; 21: 1267-9.
6. 6 ter Borg F, Smorenburg S, de Man RA, Rictbroek RC, Chamuleau RA, Jones EA. Recovery from life threatening, corticosteroid-unresponsive, chemotherapy-related reactivation of hepatitis B associated with lamivudine therapy. Dig. Dis. Sci. 1998; 43: 2267-70.
7. 7 Wainwright RB, McMahon BJ, Bender TR et. al. Prevalence of hepatitis B virus infection in Tonga: Identifying high risk groups for immunisation with hepatitis B vaccine. Int. J. Epidemiol. 1986; 15: 567-71.